Fentiazac

MUSCULO-SKELETAL SYSTEM

Key facts

Fentiazac is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including PTGDR2. Recorded indications include Pain.

• Molecular targets: PTGDR2 (1 listed in DrugCentral).
• Indications: Pain.
• ATC code: M01AB10 (Acetic acid derivatives and related substances).
• Molecular formula: C17H12ClNO2S; molecular weight 329.80 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Pain

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Prostaglandin D2 receptor 2	PTGDR2	unknown	IC50 6.26

ATC classification

ATC code	Therapeutic hierarchy
M01AB10	MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Acetic acid derivatives and related substances
M02AA14	MUSCULO-SKELETAL SYSTEM › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › Antiinflammatory preparations, non-steroids for topical use

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Fentiazac is on its molecule page.

• Molecular formula: C₁₇H₁₂ClNO₂S
• Molecular weight: 329.80 g/mol
• CAS number: 18046-21-4
• InChIKey: JIEKMACRVQTPRC-UHFFFAOYSA-N
• PubChem CID: 28871

OC(=O)CC1=C(N=C(S1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Fentiazac used for?

DrugCentral lists the following indications for Fentiazac: Pain.

How does Fentiazac work?

Its molecular targets in DrugCentral include PTGDR2.

What is the chemical formula of Fentiazac?

Fentiazac has the molecular formula C17H12ClNO2S and a molecular weight of 329.80 g/mol.

Sources

• DrugCentral drug card 1165 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL589092 — compound record and bioactivity
• PubChem CID 28871 — chemical identifiers
• DrugBank DB13217 — drug record
• FDA UNII 0YHF6E6NLS — substance identity
• UniProt Q9Y5Y4 (PTGDR2) — target protein

How this page is built: methodology · editorial policy & corrections.